UK boasts success of Cervarix vaccine programme
This article was originally published in Scrip
Executive Summary
The UK Department of Health says the work of primary care trusts on ensuring girls are immunised with the NHS-funded GlaxoSmithKline's cervical cancer vaccine, Cervarix, suggest the campaign will produce the "most successful HPV [human papillomavirus] vaccination programme in the world".